AGEasy Q2 revenue rises 1.7 times as ROAS reaches 4.7 exit

AGEasy reported Rs 34.97 crore of revenue in the second quarter of fiscal 2027 (Q2FY27), 1.7 times its Q2FY26 revenue, while return on advertising spend (ROAS) reached 4.7 at the quarter exit versus 2.0 at the Q1FY27 exit. AGEasy also recorded its highest monthly revenue, Rs 14.9 crore, in September 2026.

How fast did AGEasy revenue grow in Q2FY27?

AGEasy revenue rose to Rs 34.97 crore in Q2FY27 from Rs 20.89 crore in Q2FY26 and Rs 18.779 crore in Q1FY27, representing growth of about 1.7 times year on year and 1.9 times quarter on quarter. September 2026 revenue of Rs 14.9 crore was AGEasy's highest monthly level reported in the presentation.

AGEasy's revenue fell from Rs 20.89 crore in Q2FY26 to Rs 18.75 crore in Q3FY26, rose to Rs 22.969 crore in Q4FY26 and then declined to Rs 18.779 crore in Q1FY27 before the Q2FY27 increase. The Q2FY27 figure was Rs 12.001 crore above Q1FY27 revenue, and AGEasy reported annual recurring revenue of Rs 180 crore at the Q2FY27 exit, about twice the Q1FY27 level.

AGEasy had 89 live products and 173 stock-keeping units (SKUs), including 93 in Joint & Pain, 58 in Fall, 18 in Lung and four in Gut Health. It reported serving more than 11.7 lakh lives since inception, comprising about 8.1 lakh through marketplaces and 3.6 lakh through its direct-to-consumer (D2C) channel.

What drove AGEasy demand during the quarter?

AGEasy attributed demand growth to brand campaigns that reached more than 25 million people in Q2, alongside a 50% increase in brand searches and a 105% increase in direct web traffic from April to August. The national campaign featured Anupam Kher across YouTube, Hotstar, Inshorts and Meta, while Priyamani led a regional campaign intended to build relevance in South India.

Monthly brand searches increased from 20.8 thousand in April to 30.5 thousand in August, after measuring 20.5 thousand in May, 23 thousand in June and 26.5 thousand in July. Direct web traffic rose from 30 thousand in April to 62 thousand in August, with 32 thousand in May, 40 thousand in June and July, and 60 thousand in September.

AGEasy said it produced more than 100 creator and product-education assets a month for marketplace and D2C distribution. It reported more than 114,000 repeat customers, including more than 78,000 marketplace customers and 36,000 D2C customers, a 10% repeat rate and a net promoter score (NPS) of 49.

Which AGEasy products generated the most online revenue?

AGEasy's top 10 products generated Rs 23.8 crore in Q2FY27, representing 88% of online revenue, led by gun massagers at Rs 7.6 crore and digital blood-pressure monitors at Rs 5.9 crore. The two leading categories therefore contributed Rs 13.5 crore, or more than half of the top-10 product revenue.

Incontinence protectors ranked third with Rs 3.3 crore of Q2FY27 revenue, followed by nebulizers at Rs 1.8 crore and walking sticks at Rs 1.7 crore. Continuous glucose monitors generated Rs 90 lakh, while bunion correctors, pillows, walkers and shower chairs together generated Rs 2.6 crore.

AGEasy reported 10 design patents, including two utility patents, and one trademark. The presentation describes patented products as design-led launches across blood-pressure monitoring, mobility and personal care, while also disclosing that 39% of AGEasy's portfolio is sourced from China.

How did AGEasy advertising efficiency and margins change?

AGEasy's quarter-exit ROAS more than doubled to 4.7 in Q2FY27 from 2.0 at the Q1FY27 exit. Marketplace ROAS was 6.3 at the Q2FY27 exit, compared with 2.0 for D2C, and AGEasy's outlook identifies D2C efficiency and ROAS-led marketplace growth as mechanisms for strengthening unit economics.

Overall gross margin was 42% in Q2FY27, while online gross margin was 45% at the Q2FY27 exit. The presentation notes that gross margin excludes liquidation of non-sellable inventory, and management's outlook includes further gross-margin gains as part of its progress towards profitability.

AGEasy reported that contribution margin 2 (CM2) improved to negative 29% in Q2FY27 from negative 44% in Q2FY26 and negative 48% in Q1FY27. Management is targeting CM2 of 0% in Q3FY27 and plans to expand through quick commerce, new e-pharmacy platforms and business-to-business general trade.

Conclusion

AGEasy's Q2FY27 results show a sharp revenue increase from the preceding quarter and prior year, accompanied by a higher quarter-exit ROAS and campaign-linked growth in brand searches and direct traffic. Its online sales were concentrated in leading categories, with gun massagers and digital blood-pressure monitors generating Rs 13.5 crore and the top 10 products accounting for 88% of online revenue.

The next disclosed operating marker is management's target for CM2 to reach 0% in Q3FY27, following negative 29% in Q2FY27. Investors can also watch the execution of quick-commerce, e-pharmacy and business-to-business expansion, the trajectory of the 45% online gross margin at the Q2 exit, and the scale-up of differentiated patented products.